What Aglepristone Is and How It Works
Aglepristone, marketed in most countries as Alizin (by Virbac), is a synthetic steroid that acts as a competitive progesterone receptor antagonist. By binding to progesterone receptors without activating them, it blocks the biological effects of progesterone on the uterus. In the pregnant bitch or queen, progesterone is what maintains uterine quiescence, prevents premature contractions, and supports the placental attachment. When aglepristone blocks these receptors, the uterus loses its quiescence, contractions begin, and the pregnancy is terminated through embryonic resorption (if treated before day 25) or expulsion of fetuses (if treated later).
In this article
- What Aglepristone Is and How It Works
- Indications: When Aglepristone Is the Right Choice
- Dosing Schedule and Administration
- Confirming Pregnancy Before Treatment
- Expected Post-Treatment Course
- Side Effects and What to Watch For
- Confirming Treatment Success and Follow-Up
- Cost, Access, and Practical Considerations
- Frequently Asked Questions
The drug is the most reliable medical pregnancy termination option currently available in small animal reproductive medicine. It is more selective and better tolerated than the older prostaglandin-cabergoline combination, with predictable timing of effect and a well-characterized side effect profile. Aglepristone alizin termination is the gold-standard medical alternative to ovariohysterectomy for unwanted pregnancies in dogs and, off-label, in cats.
Aglepristone is approved and widely used in the European Union, the United Kingdom, Asia, Australia, and many other countries. In the United States it is not FDA-approved and is available only through compounding pharmacies or via legal import for specific veterinary use. This availability gap is one of the most common frustrations in US small animal reproduction practice.
Indications: When Aglepristone Is the Right Choice
The primary indication is termination of an unwanted pregnancy. Aglepristone is the preferred choice for:
- Confirmed pregnancy following a mismate or unintended breeding, in a bitch or queen whose owner does not want to continue the pregnancy
- Cases where preservation of future fertility is desired (medical termination does not compromise subsequent breeding ability)
- Patients with health concerns that make ovariohysterectomy higher-risk during pregnancy
- Pregnancies detected at later stages (up to day 45 of gestation) where other medical options have lower efficacy
Off-label indications include treatment of certain forms of open-cervix pyometra in valuable breeding bitches and management of pseudopregnancy that has not responded to cabergoline. These uses should be discussed in detail with a reproductive specialist because dosing and protocols differ from the standard termination indication.
Contraindications include known hypersensitivity to the drug or its excipients, severe hepatic or renal disease that would impair drug metabolism, and the dam being concurrently treated with progestin-containing medications. The drug is not used in male animals or in pre-pubertal patients.
Dosing Schedule and Administration
The standard aglepristone dosing protocol is straightforward: 10 milligrams per kilogram subcutaneously on day 0 and again on day 1 (two injections, 24 hours apart). The drug is supplied as a 30 milligrams per milliliter solution.
Administration tips:
- Inject subcutaneously over the scapula or in the cervical region, alternating sides between the two doses
- Massage the injection site briefly after delivery to disperse the drug
- Volumes greater than 5 milliliters per injection site should be split between two sites to reduce local reaction
- Refrigerate the vial after opening and follow manufacturer’s storage guidance
Effective treatment window: aglepristone works at any stage of gestation from pre-implantation through approximately day 45. Earlier treatment (before day 25) typically results in embryonic resorption with minimal external signs. Later treatment (day 25 to 45) results in expulsion of fetuses, which the owner will observe as vaginal discharge of fluid, placental material, and recognizable fetal tissue over a 24 to 72 hour period.
For cats, the same per-kilogram dose has been used off-label with similar efficacy, although the published evidence base is smaller. Always consult current reproductive specialist guidance for off-label use.
Confirming Pregnancy Before Treatment
Aglepristone should only be given when pregnancy is confirmed. Treating a non-pregnant bitch exposes her to drug effects without any benefit. Confirmation is best done by abdominal ultrasound from day 25 to 28 after the LH surge. Ultrasound shows embryonic vesicles, fetal heartbeats, and allows estimation of gestational age, which guides discussions about expected post-treatment outcomes.
If the owner presents within the first 25 days post-mating and wants to terminate immediately, two options exist: wait for ultrasound confirmation at day 25 and then treat (preferred for diagnostic certainty), or treat empirically based on mismate history (acceptable when timing is clearly fertile and the owner does not want to wait). The empiric approach is more common in practice when owners are highly motivated to terminate as early as possible.
Review the gestational age estimation framework in our coverage of dog pregnancy and our overview of dog pregnancy signs guide to anchor the timeline. Accurate gestational dating is critical for predicting whether resorption or expulsion will occur and counseling the owner appropriately.
Expected Post-Treatment Course
What happens after treatment depends on gestational age at the time of dosing.
Pre-implantation or very early treatment (before approximately day 22): The dam typically shows no external signs. There is no visible vaginal discharge, the bitch behaves normally, and the pregnancy resorbs silently. Recheck ultrasound at three to four weeks post-treatment confirms an empty uterus.
Mid-gestation treatment (day 25 to 35): Visible vaginal discharge develops within 5 to 7 days of the second injection. The discharge is initially clear or mucoid, then becomes brown to bloody, and may contain small recognizable fetal or placental fragments. The bitch may appear mildly uncomfortable, may have decreased appetite, and may seek isolation. The expulsion phase lasts 24 to 72 hours.
Later treatment (day 36 to 45): Expulsion is more dramatic and may include fully formed (though non-viable) fetuses. The bitch may show signs that resemble premature whelping, including restlessness, panting, and abdominal contractions. Owners should be prepared for this in advance because seeing recognizable fetuses can be distressing.
The dam’s behavior during and after treatment should be monitored. Provide a quiet, clean environment, fresh water, and easy access to outdoor elimination. Avoid handling the dam excessively. Most bitches return to normal behavior within 3 to 5 days after expulsion is complete.
Side Effects and What to Watch For
Aglepristone is generally well tolerated. The most common side effects are transient and self-limiting, but owners and clinicians should know what to look for.
Mild local reaction at the injection site (swelling, mild pain, occasional small abscess formation) is the most frequent adverse event. Most resolve without treatment within 1 to 2 weeks. Larger or persistent reactions warrant veterinary evaluation.
Transient vaginal discharge (described above as the expected mid-gestation expulsion) is part of the therapeutic effect rather than a true adverse event. However, any discharge that becomes foul-smelling, purulent, or is associated with systemic illness (fever, lethargy, anorexia) suggests secondary infection or a pyometra-like complication and requires immediate veterinary evaluation. Compare with the clinical picture in our overview of pyometra in dogs.
Anorexia and mild lethargy during the expulsion phase are common and resolve within 48 to 72 hours. Persistent anorexia beyond this period suggests a complication and warrants reassessment.
Rare but reported adverse effects include uterine inertia in dams treated very late in gestation (failure to expel all fetuses, requiring assistance with oxytocin or surgery), and prolonged interestrus interval (the next heat cycle may be delayed by several weeks to several months compared with the dam’s usual pattern).
Confirming Treatment Success and Follow-Up
Post-treatment follow-up is essential. The standard plan includes a recheck ultrasound at 10 to 14 days after the second injection to confirm absence of viable fetuses, and a second recheck at four weeks to confirm complete uterine evacuation and return to normal anatomy.
Vaginal cytology at the four-week recheck can confirm absence of trophoblastic material and rule out subinvolution-like residual lesions, though clinically significant subinvolution after aglepristone-induced termination is rare.
If ultrasound at the first recheck shows persistent viable fetuses, retreatment with the same dosing protocol can be considered, although secondary treatment failure should prompt review of the original dosing accuracy and consideration of ovariohysterectomy as the definitive alternative.
Counsel the owner about expected timing of the next heat cycle. Most bitches return to estrus within 1 to 6 months after aglepristone treatment, though some experience longer interestrus intervals. Future fertility is generally unaffected, and aglepristone-treated bitches can have normal subsequent pregnancies.
Cost, Access, and Practical Considerations
Aglepristone is not inexpensive. In countries where the drug is approved (Alizin in the EU, Asia, Australia), expect a total medication cost of several hundred US dollars equivalent for a medium-sized bitch, before accounting for veterinary visits and recheck ultrasounds. In the US, compounded aglepristone may be even more expensive due to compounding fees and limited availability.
Cost comparison with ovariohysterectomy varies by region. In some areas medical termination costs more than spay; in others the reverse is true. The decision between the two should be based primarily on the owner’s desire to preserve future breeding ability rather than on cost differences, which are typically modest in the broader context of pet ownership.
For owners pursuing aglepristone, schedule the full course (initial visit with ultrasound confirmation, two injection visits 24 hours apart, follow-up ultrasound at 2 weeks, and four-week recheck) before starting. The treatment requires commitment to follow-through. Compare with other mismate options and our spaying and neutering guide when discussing the choice with the owner.
Frequently Asked Questions
How effective is aglepristone for pregnancy termination?
Published efficacy rates are 95 to 99 percent when given at the standard dose within the approved gestational window. Treatment failures are rare and usually relate to under-dosing or very-late-gestation administration.
Can I get aglepristone in the United States?
Not as an FDA-approved product. It is available through veterinary compounding pharmacies and through legal import for specific cases. Discuss with a board-certified theriogenologist or your veterinarian for current sourcing options.
Will aglepristone affect my dog’s ability to have future litters?
Generally no. Most treated bitches return to normal cyclic activity and have successful subsequent pregnancies. Some experience a delayed next heat cycle, which does not affect long-term fertility.
What if my dog is in the middle of treatment and seems unwell?
Mild lethargy and anorexia during the expulsion phase are expected. Fever, foul vaginal discharge, persistent vomiting, or collapse are not expected and require immediate veterinary evaluation for possible secondary pyometra or other complication.
How soon after treatment can I have her spayed?
Wait until the four-week post-treatment ultrasound confirms an empty, involuted uterus. At that point routine OHE can be scheduled following standard spay recovery for dogs protocols.